CG Oncology (CGON) is up 16.0%, or $6.70 to $48.63.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CGON:
- CG Oncology Accelerates Phase 3 Bladder Cancer Trial Timeline
- CG Oncology expects PIVOT-006 Phase 3 topline data in 1H26
- CG Oncology price target raised to $89 from $82 at Morgan Stanley
- CG Oncology price target raised to $62 from $60 at BofA
- These Are the Most and Least Likely Biotech Takeover Targets for 2026